Journal article
Viral Respiratory Tract Infections in Allogeneic Hematopoietic Stem Cell Transplantation Recipients in the Era of Molecular Testing
SA Sim, VKY Leung, D Ritchie, MA Slavin, SG Sullivan, BW Teh
Biology of Blood and Marrow Transplantation | Published : 2018
Open access
Abstract
Viral respiratory tract infection (vRTI) is a significant cause of morbidity and mortality in patients undergoing allogeneic hematopoietic stem cell transplantation (allo-HSCT). This study aimed to assess the epidemiologic characteristics, risk factors, and outcomes of vRTI occurring in the period from conditioning to 100 days after allo-HSCT in the era of molecular testing. This study was a retrospective record review of patients who underwent allo-HSCT at Royal Melbourne Hospital between January 2010 and December 2015. Symptomatic patients were tested using respiratory multiplex polymerase chain reaction (PCR). Logistic regression and Kaplan-Meier analysis were used to identify risk factor..
View full abstractGrants
Funding Acknowledgements
The World Health Organization Collaborating Centre for Reference and Research on Influenza is supported by the Australian Government Department of Health. B.W.T. is supported by a Peter MacCallum Cancer Centre Clinical Research Fellowship and a National Health and Medical Research Council Early Career Fellowship.